Showing results (11-20 of 56) with videos related to
Sort By:
Pageof 6
Clinical Calcium|December 28, 2017
[Bone-derived hormones and their systemic regulation.]Yuichi Takashi, Seiji Fukumoto, Toshio MatsumotoInternational Journal of Molecular Sciences|June 18, 2020
Significance of Metformin Use in Diabetic Kidney DiseaseDaiji Kawanami, Yuichi Takashi, Makito TanabeCurrent Opinion in Endocrinology, Diabetes, and Obesity|April 30, 2024
Recent advances in fibroblast growth factor 23-related hypophosphatemic disordersYuichi Takashi, Daiji Kawanami, Seiji FukumotoAntioxidants (Basel, Switzerland)|February 10, 2021
Renoprotective Effects of DPP-4 InhibitorsDaiji Kawanami, Yuichi Takashi, Hiroyuki Takahashi, et al.Medical Molecular Morphology|July 1, 2015
ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumorsShogo Tajima, Yuichi Takashi, Nobuaki Ito, et al.Journal of Bone and Mineral Metabolism|December 5, 2019
How do we sense phosphate to regulate serum phosphate level?Seiji Fukumoto, Yuichi Takashi, Maria K Tsoumpra, et al.Plos One|May 2, 2018
Circulating pentraxin 3 is positively associated with chronic hyperglycemia but negatively associated with plasma aldosterone concentrationYuichi Takashi, Minae Koga, Yoko Matsuzawa, et al.Endocrine Research|October 19, 2016
Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophyYuichi Takashi, Yuka Kinoshita, Michiko Hori, et al.Journal of Diabetes Investigation|November 28, 2016
Undercarboxylated osteocalcin can predict insulin secretion ability in type 2 diabetesYuichi Takashi, Minae Koga, Yoko Matsuzawa, et al.Frontiers in Pharmacology|November 18, 2021
Mineralocorticoid Receptor Antagonists in Diabetic Kidney DiseaseDaiji Kawanami, Yuichi Takashi, Yoshimi Muta, et al.Pageof 6